Thursday, 25 April 2024 04:25 AM
OR
Login using
New data shows GSK-Vir drug works against all Omicron mutations
December 7, 2021 15:47 pm
Dec 7: British drugmaker GSK (GSK.L) said on Tuesday its antibody-based COVID-19 therapy with U.S. partner Vir Biotechnology (VIR.O) is effective against all mutations of the new Omicron coronavirus variant, citing new data from early-stage studies.
Trending
Just In
- Health ministry to conduct ‘search and vaccinate’ campaign on May 13
- Indian customs releases trucks carrying Nepali tea, halted across Kakarbhitta
- Silent period for by-election to begin from midnight
- SC issues short-term interim order to govt and TU not to take immediate action against TU legal advisor Khanal
- National consultation workshop advocates to scale up nutrition smart community in Nepal
- Patan High Court issues short-term interim order to halt selection process of NTB’s CEO
- NEPSE inches up 0.15 points; daily turnover increases to Rs 2.53 billion
- Bagmati Govt mandates tri-lingual signboards in offices